Carr Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$850K Buy
5,851
+599
+11% +$82.8K 0.19% 83
2026
Q2
$675K Buy
5,252
+62
+1% +$7.26K 0.16% 92
2026
Q1
$624K Buy
5,190
+58
+1% +$6.7K 0.16% 87
2025
Q4
$540K Buy
5,132
+59
+1% +$5.54K 0.14% 100
2025
Q3
$426K Sell
5,073
-452
-8% -$37.2K 0.12% 113
2025
Q2
$437K Sell
5,525
-405
-7% -$32.2K 0.13% 104
2025
Q1
$532K Sell
5,930
-2,718
-31% -$254K 0.17% 87
2024
Q4
$860K Buy
8,648
+457
+6% +$47.1K 0.27% 67
2024
Q3
$930K Buy
8,191
+58
+0.7% +$6.89K 0.27% 68
2024
Q2
$1.01M Buy
8,133
+109
+1% +$14K 0.32% 59
2024
Q1
$1.06M Hold
8,024
– – 0.35% 57
2023
Q4
$875K Hold
8,024
– – 0.32% 60
2023
Q3
$830K Sell
8,024
-335
-4% -$36.1K 0.33% 59
2023
Q2
$971K Sell
8,359
-90
-1% -$10.2K 0.39% 49
2023
Q1
$905K Buy
8,449
+297
+4% +$32.1K 0.4% 49
2022
Q4
$910K Buy
+8,152
New +$833K 0.48% 44

Other funds holding MRK

Carr Financial Group's MRK Position: Q3 2026 in Review

Carr Financial Group increased its Merck (MRK) stake by 11% in Q3 2026, buying an estimated $82.8K and bringing the position to 5,851 shares worth $850K. The position accounts for 0.19% of the portfolio, ranked #83.

Carr Financial Group first reported a position in MRK in Q4 2022 and has held it in 16 quarters since. The position peaked at $1.06M in Q1 2024. 3,967 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Carr Financial Group held 5,851 shares of Merck worth $850K as of Q3 2026.
  • Carr Financial Group bought 599 Merck shares in Q3 2026, an estimated $82.8K.
  • Merck made up 0.19% of Carr Financial Group's portfolio in Q3 2026, its #83 holding.
  • Carr Financial Group first reported a position in Merck in Q4 2022 and has held it in 16 quarters since.
  • Carr Financial Group's Merck position peaked at $1.06M in Q1 2024.
  • 3,967 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Carr Financial Group's 13F filing for Q3 2026, filed 10 Nov 2026.